Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Sufentanil
Status:
Not yet recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
This study will examine how sufentanil (a commonly used pain medication) will alter responses
to simulated blood loss in humans. To simulate blood loss in the research laboratory,
participants will complete a test with their lower body in a custom-designed vacuum chamber
for a brief period of time.